Your browser doesn't support javascript.
loading
Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation.
Matsukawa, Toshihiro; Izawa, Kumi; Isobe, Masamichi; Takahashi, Mariko; Maehara, Akie; Yamanishi, Yoshinori; Kaitani, Ayako; Okumura, Ko; Teshima, Takanori; Kitamura, Toshio; Kitaura, Jiro.
Affiliation
  • Matsukawa T; Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Izawa K; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan.
  • Isobe M; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Takahashi M; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Maehara A; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Yamanishi Y; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kaitani A; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Okumura K; Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan.
  • Teshima T; Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
  • Kitamura T; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan Division of Stem Cell Signaling, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kitaura J; Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan.
Gut ; 65(5): 777-87, 2016 May.
Article in En | MEDLINE | ID: mdl-25673319
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Immunologic / Ceramides / Adenosine Triphosphate / Colitis / Mast Cells Type of study: Prognostic_studies Limits: Animals Language: En Journal: Gut Year: 2016 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Immunologic / Ceramides / Adenosine Triphosphate / Colitis / Mast Cells Type of study: Prognostic_studies Limits: Animals Language: En Journal: Gut Year: 2016 Type: Article Affiliation country: Japan